From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. HIV/AIDS Clinical Care>
  4. News in Context

HIV/AIDS Clinical Care: News in Context

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.


to
Items 11-20 of 46 are shown

Which ART Regimen Is Best After Receipt of Single-Dose Nevirapine?

Preliminary results from the OCTANE trial suggest that lopinavir/r-based regimens are more effective than nevirapine-based ones, particularly when ART is initiated shortly after exposure to single-dose nevirapine.

  • By Catherine Tomeo Ryan
  • November 17, 2008

Concurrent ART/TB Treatment Finally Proven to Be Beneficial

Giving ART while TB treatment was still ongoing dramatically improved survival among HIV/TB-coinfected patients in a large clinical trial in South Africa.

  • By ACC Editors
  • September 29, 2008

HIV Vaccine Trial Canceled

NIAID will not conduct the HIV vaccine study known as PAVE 100. Instead, officials are considering a smaller, more focused trial.

  • By Dan H. Barouch, MD, PhD
  • August 4, 2008

FTC + Atazanavir + ddI Deemed Inferior to AZT/3TC + Efavirenz

Patients receiving FTC + atazanavir + ddI in an ongoing ACTG trial are being switched to other regimens but will continue to be followed.

Abacavir/3TC vs. Tenofovir/FTC: Interim Results from ACTG 5202

An interim analysis from ACTG 5202 suggests that abacavir/3TC is not as effective as tenofovir/FTC in reducing viral load among treatment-naive patients with high viral loads (100,000 or more copies/mL) at baseline.

HIV-1 Vaccine Might Increase Infection Risk in Certain Subgroups

The HIV-1 vaccine used in the STEP trial has already been shown to be ineffective, but might it actually cause harm?

HIV-1 Vaccine Candidate Ineffective

The vaccine used in the international STEP trial failed to prevent HIV-1 infection and also did not reduce viral load in those who became infected.

  • By Dan H. Barouch, MD, PhD
  • October 1, 2007

Anti-HIV Microbicide Trials Halted

Preliminary results indicate that the risk for HIV infection is higher among women using cellulose sulfate than among those using placebo.

  • By ACC Editors
  • February 12, 2007

Circumcision Greatly Reduces Risk for HIV Infection

Adult male circumcision halved the risk for HIV transmission in an interim analysis of two randomized, controlled studies.

  • December 22, 2006

APTIMA Assay Approved for HIV Testing

For the first time, the FDA has recognized a nucleic-acid test as a tool for diagnosing HIV infection.

  • By Rochelle P. Walensky, MD, MPH
  • October 30, 2006
Items 11-20 of 46 are shown

to

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?





Copyright © 2013. Massachusetts Medical Society. All rights reserved.